An elderly case of ceftriaxone-associated pseudolithiasis that developed during therapy for acute pneumonia

Kazufumi Dohmen, Asataro Yamamoto, Hirofumi Tanaka, Masatora Haruno, Shinji Shimoda

研究成果: ジャーナルへの寄稿記事

1 引用 (Scopus)

抄録

A 76-year-old male was referred to our hospital due to symptoms of a high fever and cough. He was diagnosed to have pneumonia based on the X-ray findings and elevated white blood cell counts and CRP. Ceftriaxone (CTRX) at a dose of 2 g per day was administered. He complained of right hypochondralgia at eight days after the start of CTRX treatment. A laboratory examination showed the elavated levels of AST of 587 IU/l, ALT 311 IU/l and ALP 709 IU/l, respectively. US, CT and MRI revealed an abnormally thick gallbladder wall in addition to the presence of sludge and a stone. He was diagnosed to have CTRX-associated pseudolithiasis. His complaints and abnormal findings confirmed by CT resolved completely after the discontinuation of CTRX therapy. We should therefore be aware of the fact that the administration of CTRX may sometimes cause the formation of biliary sludge or stones which can possibly lead to the onset of adverse events, not only in children, but also in elderly patients.

元の言語英語
ページ(範囲)106-112
ページ数7
ジャーナルActa Hepatologica Japonica
57
発行部数2
DOI
出版物ステータス出版済み - 3 3 2016

Fingerprint

Ceftriaxone
Pneumonia
Therapeutics
Sewage
Gallbladder
Leukocyte Count
Cough
Bile
Fever
X-Rays

All Science Journal Classification (ASJC) codes

  • Hepatology

これを引用

An elderly case of ceftriaxone-associated pseudolithiasis that developed during therapy for acute pneumonia. / Dohmen, Kazufumi; Yamamoto, Asataro; Tanaka, Hirofumi; Haruno, Masatora; Shimoda, Shinji.

:: Acta Hepatologica Japonica, 巻 57, 番号 2, 03.03.2016, p. 106-112.

研究成果: ジャーナルへの寄稿記事

Dohmen, Kazufumi ; Yamamoto, Asataro ; Tanaka, Hirofumi ; Haruno, Masatora ; Shimoda, Shinji. / An elderly case of ceftriaxone-associated pseudolithiasis that developed during therapy for acute pneumonia. :: Acta Hepatologica Japonica. 2016 ; 巻 57, 番号 2. pp. 106-112.
@article{c2f820a31fa946f29b2116918a93455b,
title = "An elderly case of ceftriaxone-associated pseudolithiasis that developed during therapy for acute pneumonia",
abstract = "A 76-year-old male was referred to our hospital due to symptoms of a high fever and cough. He was diagnosed to have pneumonia based on the X-ray findings and elevated white blood cell counts and CRP. Ceftriaxone (CTRX) at a dose of 2 g per day was administered. He complained of right hypochondralgia at eight days after the start of CTRX treatment. A laboratory examination showed the elavated levels of AST of 587 IU/l, ALT 311 IU/l and ALP 709 IU/l, respectively. US, CT and MRI revealed an abnormally thick gallbladder wall in addition to the presence of sludge and a stone. He was diagnosed to have CTRX-associated pseudolithiasis. His complaints and abnormal findings confirmed by CT resolved completely after the discontinuation of CTRX therapy. We should therefore be aware of the fact that the administration of CTRX may sometimes cause the formation of biliary sludge or stones which can possibly lead to the onset of adverse events, not only in children, but also in elderly patients.",
author = "Kazufumi Dohmen and Asataro Yamamoto and Hirofumi Tanaka and Masatora Haruno and Shinji Shimoda",
year = "2016",
month = "3",
day = "3",
doi = "10.2957/kanzo.57.106",
language = "English",
volume = "57",
pages = "106--112",
journal = "Acta Hepatologica Japonica",
issn = "0451-4203",
publisher = "Japan Society of Hepatology",
number = "2",

}

TY - JOUR

T1 - An elderly case of ceftriaxone-associated pseudolithiasis that developed during therapy for acute pneumonia

AU - Dohmen, Kazufumi

AU - Yamamoto, Asataro

AU - Tanaka, Hirofumi

AU - Haruno, Masatora

AU - Shimoda, Shinji

PY - 2016/3/3

Y1 - 2016/3/3

N2 - A 76-year-old male was referred to our hospital due to symptoms of a high fever and cough. He was diagnosed to have pneumonia based on the X-ray findings and elevated white blood cell counts and CRP. Ceftriaxone (CTRX) at a dose of 2 g per day was administered. He complained of right hypochondralgia at eight days after the start of CTRX treatment. A laboratory examination showed the elavated levels of AST of 587 IU/l, ALT 311 IU/l and ALP 709 IU/l, respectively. US, CT and MRI revealed an abnormally thick gallbladder wall in addition to the presence of sludge and a stone. He was diagnosed to have CTRX-associated pseudolithiasis. His complaints and abnormal findings confirmed by CT resolved completely after the discontinuation of CTRX therapy. We should therefore be aware of the fact that the administration of CTRX may sometimes cause the formation of biliary sludge or stones which can possibly lead to the onset of adverse events, not only in children, but also in elderly patients.

AB - A 76-year-old male was referred to our hospital due to symptoms of a high fever and cough. He was diagnosed to have pneumonia based on the X-ray findings and elevated white blood cell counts and CRP. Ceftriaxone (CTRX) at a dose of 2 g per day was administered. He complained of right hypochondralgia at eight days after the start of CTRX treatment. A laboratory examination showed the elavated levels of AST of 587 IU/l, ALT 311 IU/l and ALP 709 IU/l, respectively. US, CT and MRI revealed an abnormally thick gallbladder wall in addition to the presence of sludge and a stone. He was diagnosed to have CTRX-associated pseudolithiasis. His complaints and abnormal findings confirmed by CT resolved completely after the discontinuation of CTRX therapy. We should therefore be aware of the fact that the administration of CTRX may sometimes cause the formation of biliary sludge or stones which can possibly lead to the onset of adverse events, not only in children, but also in elderly patients.

UR - http://www.scopus.com/inward/record.url?scp=84959456854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959456854&partnerID=8YFLogxK

U2 - 10.2957/kanzo.57.106

DO - 10.2957/kanzo.57.106

M3 - Article

AN - SCOPUS:84959456854

VL - 57

SP - 106

EP - 112

JO - Acta Hepatologica Japonica

JF - Acta Hepatologica Japonica

SN - 0451-4203

IS - 2

ER -